The role of PRAME immunohistochemistry in the diagnostic approach to melanocytic lesions | 30 min
PRAME is a tumour-associated antigen identified by autologous T-cell epitope in a patient with metastatic cutaneous melanoma.
In this presentation Pathologist Dr Robert Rawson discusses:
- the history and context of PRAME immunohistochemistry
- the role in assessment of cutaneous melanocytic lesions
- other roles of PRAME including nodal deposits, margin assessment, assessment of melanocytic lesions at other sites, and using PRAME in undifferentiated malignancies.
Dr Robert Rawson
Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital
Declaration of Interest